Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cruz, M. E.
Right arrow Articles by Dumas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruz, M. E.
Right arrow Articles by Dumas, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 28, 799-803, Copyright © 1999 by International Epidemiological Association


ARTICLES

Epilepsy and neurocysticercosis in an Andean community

ME Cruz, PM Schantz, I Cruz, P Espinosa, PM Preux, A Cruz, W Benitez, VC Tsang, J Fermoso and M Dumas
Institute for Tropical Neurology, Unit of Neurosciences, Central University School of Medicine, Quito, Ecuador.

BACKGROUND: Taenia solium neurocysticercosis (NCC) has been documented as one of the major causes of epilepsy in developing countries. However, methodological limitations have hindered the evaluation of the epidemiological relationship between cysticercosis and epilepsy at the community level. METHODS: We used the WHO protocol for epidemiological evaluation of neurological disorders to conduct a door-to-door survey among 2723 residents of San Pablo del Lago, an Ecuadorean rural community in which T. solium taeniasis/cysticercosis was known to be endemic. The WHO protocol was complemented by neuroimaging and immunological tests to confirm the diagnosis of this infection. RESULTS: In all 31 people suffering from active epilepsy were detected (prevalence 11.4 per 1000, 95% CI:7.7-15.4); 26 agreed to undergo a computer tomography (CT) examination, and 28 agreed to have blood drawn for serodiagnosis. Fourteen of the 26 (53.8%) had CT changes compatible with NCC and six of the 28 (21.4%) tested positive in the enzyme-linked immunoelectro-transfer blot (EITB) assay. In a seizure-free random sample of this population, 17 of 118 (144 per 1000) subjects examined by CT and 10 out of 96 (104 per 1000) examined by EITB had evidence of this infection. The differences between the epilepsy group and the random sample of the population were statistically significant (OR = 6.93, 95% CI: 2.7-17.5, P < 0.001) for CT diagnosis, but not for EITB results (OR = 2.75, 95% CI: 0.8-7.1, P > 0.12, NS). CONCLUSIONS: These findings confirm that T. solium NCC is a significant cause of epilepsy at the community level in Andean villages of Ecuador. It is important to initiate effective public health interventions to eliminate this infection, which may be responsible for at least half of the cases of reported epilepsy in Ecuador.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
V. Rajshekhar, M. V. Raghava, V. Prabhakaran, A. Oommen, and J. Muliyil
Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India
Neurology, December 26, 2006; 67(12): 2135 - 2139.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. E. Nash, G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proano, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. DeGiorgio, et al.
Treatment of neurocysticercosis: current status and future research needs.
Neurology, October 10, 2006; 67(7): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. M. Montano, M. V. Villaran, L. Ylquimiche, J. J. Figueroa, S. Rodriguez, C. T. Bautista, A. E. Gonzalez, V.C.W. Tsang, R. H. Gilman, H. H. Garcia, et al.
Neurocysticercosis: Association between seizures, serology, and brain CT in rural Peru
Neurology, July 26, 2005; 65(2): 229 - 233.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
H. H. GARCIA, O. H. DEL BRUTTO, T. E. NASH, A. C. WHITE JR., V. C. W. TSANG, and R. H. GILMAN
NEW CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF NEUROCYSTICERCOSIS (TAENIA SOLIUM)
Am J Trop Med Hyg, January 1, 2005; 72(1): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. E. Nash, O. H. Del Brutto, J. A. Butman, T. Corona, A. Delgado-Escueta, R. M. Duron, C. A.W. Evans, R. H. Gilman, A. E. Gonzalez, J. A. Loeb, et al.
Calcific neurocysticercosis and epileptogenesis
Neurology, June 8, 2004; 62(11): 1934 - 1938.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
H. H. GARCIA, R. H. GILMAN, A. E. GONZALEZ, M. VERASTEGUI, S. RODRIGUEZ, C. GAVIDIA, V. C. W. TSANG, N. FALCON, A. G. LESCANO, L. H. MOULTON, et al.
HYPERENDEMIC HUMAN AND PORCINE TAENIA SOLIUM INFECTION IN PERU
Am J Trop Med Hyg, March 1, 2003; 68(3): 268 - 275.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Robinson, A. C. White, D. E. Lewis, J. Thornby, E. David, and J. Weinstock
Sequential Expression of the Neuropeptides Substance P and Somatostatin in Granulomas Associated with Murine Cysticercosis
Infect. Immun., August 1, 2002; 70(8): 4534 - 4538.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Nicoletti, A. Bartoloni, A. Reggio, F. Bartalesi, M. Roselli, V. Sofia, J. Rosado Chavez, H. Gamboa Barahona, F. Paradisi, G. Cancrini, et al.
Epilepsy, cysticercosis, and toxocariasis: A population-based case-control study in rural Bolivia
Neurology, April 23, 2002; 58(8): 1256 - 1261.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.